H.C. Wainwright Starts I-Mab (IMAB) at Buy, $55 PT
Tweet Send to a Friend
(updated to add analyst comments)H.C. Wainwright analyst Andrew Fein initiates coverage on I-Mab (NASDAQ: IMAB) with a Buy rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE